Epithalon vs GHK-Cu
Both compounds are short peptides with aging-related research profiles, but the published mechanistic work examines different molecular targets in different model systems. Epithalon has been studied for telomerase regulation and telomere-length maintenance. GHK-Cu has been studied for copper-mediated skin remodeling and antioxidant chemistry. This page summarises the published distinctions.
Side-by-side comparison
| Property | Compound A | Compound B |
|---|---|---|
| Structural class | Tetrapeptide (Ala-Glu-Asp-Gly); synthetic pineal-peptide analogue | Tripeptide-copper(II) complex (Gly-His-Lys-Cu2+) |
| Approximate molecular weight | 390.3 g/mol | 402.91 g/mol (Cu-bound form) |
| Best-studied mechanism | Telomerase upregulation; telomere-length maintenance; melatonin-synthesis modulation | Copper-mediated antioxidant chemistry; MMP and collagen expression modulation in dermal fibroblasts |
| Primary research domain | Aging biology, telomere research, carcinogenesis inhibition, neurogenesis | Skin remodeling, hair follicle, wound-bed ECM, oxidative-stress chemistry |
| Distinctive feature | Pineal-gland origin; telomerase-level action | Bound copper ion is integral to the active species |
| Common research routes | Intraperitoneal, intranasal | Topical, subcutaneous |
| Ronin catalog vial size | 10 mg lyophilised | 50 mg lyophilised |
How they differ in mechanism
Epithalon (AEDG tetrapeptide) has been investigated for telomerase-upregulation activity. The published literature includes telomere-length increases in human cell lines (Al-Dulaimi et al., 2025), lifespan extension in Drosophila melanogaster, carcinogenesis inhibition in rodent models, oocyte-aging protection, and neurogenesis-related gene-expression modulation. The mechanistic frame centres on cellular-senescence biology and telomere maintenance at the nuclear level.
GHK-Cu operates through copper-bound-tripeptide chemistry. The Cu2+ ion is integral to the active species. Published work reports reactive-carbonyl quenching, modulation of integrin and p63 expression in keratinocytes, altered MMP and collagen expression in dermal fibroblasts, and broad gene-expression effects relevant to skin regeneration and wound healing. Recent work has extended into lung-fibrosis models.
Both compounds touch the broad aging-research space but through different molecular mechanisms at different subcellular targets. Epithalon acts at the telomere-maintenance level in the nucleus. GHK-Cu acts at the extracellular-matrix and redox-chemistry level in skin and connective tissue. The overlap is thematic (both relate to aging) rather than mechanistic.
How research has examined each
The epithalon literature spans Khavinson and colleagues’ work on pineal-peptide biology, including lifespan studies, carcinogenesis-inhibition experiments, neurogenesis gene-expression work, oocyte-aging protection, and the recent telomere-length characterisation in human cell lines. The research community is gerontology and aging biology.
The GHK-Cu literature spans Pickart and colleagues’ work on skin-remodeling biology, oxidative-stress chemistry, and gene-expression profiling in dermal fibroblasts and keratinocytes. Recent extensions include lung-fibrosis models and zebrafish-inflammation models. The research community is dermatology and cosmetic science.
The two literatures share the aging-research umbrella but occupy different mechanistic and tissue-specific niches. Epithalon is read by telomere biologists. GHK-Cu is read by dermatology and matrix-biology researchers.
Stacking considerations in research contexts
Combined administration of epithalon and GHK-Cu is not described in published research. The mechanisms (telomerase regulation versus copper-mediated matrix remodeling) target different subcellular systems. Epithalon ships at 10 mg and GHK-Cu at 50 mg in the Ronin catalog.
Sourcing both at Ronin
The Epithalon vial page provides 10 mg per vial. The GHK-Cu vial page provides 50 mg per vial. Both ship as lyophilised peptide in glass vials with certificate-of-analysis documentation. Both are research-grade reagents.
Frequently asked research questions
Are epithalon and GHK-Cu related?
No. Epithalon is a pineal-derived tetrapeptide for telomere research. GHK-Cu is a copper-bound tripeptide for skin-remodeling research. Different sequences, mechanisms, and tissues.
Both relate to aging — do they share a mechanism?
The aging-research context is thematic, not mechanistic. Epithalon acts on telomerase at the nuclear level. GHK-Cu acts on matrix remodeling and redox chemistry at the tissue level.
Why is the GHK-Cu vial larger?
GHK-Cu has a low molecular weight and is conventionally supplied at higher absolute mass. The 50 mg vial reflects standard research-supply conventions.
Are they stacked?
Not in published research.
Are either approved for human use?
Neither is approved by the FDA or Health Canada. Both are research-grade reagents.
References
- Khavinson VK et al. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mechanisms of Ageing and Development, 2000. [PMID 11087911]
- Pickart L et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015. [PMID 26236730]
- Pickart L et al. Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences, 2018. [PMID 29986520]
- Khavinson V et al. AEDG Peptide (Epitalon) Stimulates Gene Expression during Neurogenesis. Molecules, 2020. [PMID 32019204]
- Araj SK et al. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide. International Journal of Molecular Sciences, 2025. [PMID 40141333]
- Al-Dulaimi S et al. Epitalon increases telomere length in human cell lines. Biogerontology, 2025. [PMID 40908429]
Comparison pages describe research-context use of the compared compounds. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.